Previous 10 | Next 10 |
Centogene (NASDAQ: CNTG ) has priced its primary and secondary public offering of 3.5M common shares (2M Company's shares and 1.5M by the selling shareholders) at $14.00/share for total gross proceeds of $28M to the Company and $21M to the selling shareholders. More news on: Ce...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actiona...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that its paper ‘Rapid Large-Scale COVID-19 Testing During Shortages’ has been publish...
Gainers: Senmiao Technology (NASDAQ: AIHS ) +71% . More news on: Senmiao Technology Limited, National General Holdings Corp., Tantech Holdings Ltd, Stocks on the move, , Read more ...
Centogene (NASDAQ: CNTG ) commences a public offering of 3.5M common shares (2M shares of the Company and 1.5M offered by the selling shareholders). More news on: Centogene N.V., Healthcare stocks news, , Read more ...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutica...
CAMBRIDGE, Mass. and SANTA MONICA, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an innovation network of more than 600 schools across the U.S., today announced a partnership f...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutica...
Centogene (NASDAQ: CNTG ) has partnered exclusively with Lufthansa and with Fraport, the operator of Frankfurt Airport, to offer COVID-19 testing to passengers flying to and from Frankfurt Airport (FRA). More news on: Centogene N.V., Healthcare stocks news, Stocks on the move, R...
Lufthansa becomes first globally leading airline with a solution for safe and convenient international air travel during this pandemic Landmark exclusive cooperation offers testing for passengers departing from or arriving at Frankfurt airport starting immediately Innovative concept supp...
News, Short Squeeze, Breakout and More Instantly...
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answer...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the Company ...
CXApp Inc. (CXAI) is expected to report for quarter end 2024-03-31 Purple Biotech Ltd. (PPBT) is expected to report $-0.15 for Q1 2024 AutoZone Inc. (AZO) is expected to report $35.72 for Q3 2024 Turkcell Iletisim Hizmetleri AS (TKC) is expected to report for Q1 2024 Orkla ASA ADR...